| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1529-0131(200001)43:1<65::AID-ANR9>3.0.CO;2-I |
| P698 | PubMed publication ID | 10643701 |
| P2093 | author name string | Y Kawakami | |
| Y Ikeda | |||
| N Hattori | |||
| T Mimori | |||
| M Kuwana | |||
| J Kaburaki | |||
| P2860 | cites work | The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions | Q24302208 |
| Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) | Q24558202 | ||
| Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody | Q24564513 | ||
| Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant | Q24633473 | ||
| How can cryptic epitopes trigger autoimmunity? | Q24678950 | ||
| Novel packages of viral and self-antigens are generated during apoptosis | Q27485110 | ||
| Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I | Q28304443 | ||
| Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation | Q28305356 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies | Q33388194 | ||
| Anticardiolipin antibodies: isotype distribution and phospholipid specificity | Q33456927 | ||
| Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice | Q33491319 | ||
| Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus | Q33496557 | ||
| The syndrome of thrombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antiphospholipid antibodies: Hughes syndrome | Q33497584 | ||
| Lupus anticoagulants/antiphospholipid-protein antibodies: the great imposters | Q33497594 | ||
| How some T cells escape tolerance induction | Q34418421 | ||
| T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors | Q35751372 | ||
| Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H). | Q35822651 | ||
| The inability to process a self-peptide allows autoreactive T cells to escape tolerance | Q36361234 | ||
| Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen | Q36362919 | ||
| The antiphospholipid syndrome: ten years on. | Q40711282 | ||
| Self antigens and epitope spreading in systemic autoimmunity | Q41564944 | ||
| Complete nucleotide and deduced amino acid sequence of human β2-glycoprotein I | Q41674799 | ||
| Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface | Q42084495 | ||
| The T cell repertoire against cryptic self determinants and its involvement in autoimmunity and cancer | Q46913567 | ||
| Amino acid sequence and location of the disulfide bonds in bovine .beta.2 glycoprotein I: the presence of five Sushi domains | Q53780809 | ||
| Major histocompatibility complex associations with primary antiphospholipid syndrome | Q58143748 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 65-75 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals | |
| P478 | volume | 43 |
| Q64056547 | Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome |
| Q35215762 | Anti-beta(2)-glycoprotein I antibodies and the antiphospholipid syndrome |
| Q40858020 | Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome. |
| Q34108963 | Antiphospholipid antibodies and platelets |
| Q35171951 | Autoreactive CD4(+) T cells to beta(2)-glycoprotein I in patients with antiphospholipid syndrome |
| Q28344126 | Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis |
| Q24307173 | Binding of beta 2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells |
| Q37351603 | Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients |
| Q33417625 | Induction of immune tolerance to platelet antigen by short-term thrombopoietin treatment in a mouse model of immune thrombocytopenia |
| Q37903952 | Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I. |
| Q38678297 | Patient-derived anti-β2GP1 antibodies recognize a peptide motif pattern and not a specific sequence of residues |
| Q36960925 | Systemic antiphospholipid syndrome and atherosclerosis |
| Q36194551 | T cells demonstrate a Th1-biased response to native beta2-glycoprotein I in a murine model of anti-phospholipid antibody induction |
| Q52724555 | T cells from induced and spontaneous models of SLE recognize a common T cell epitope on β2-glycoprotein I. |
| Q33365380 | The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura |
| Q35580535 | The role of jo-1 in the immunopathogenesis of polymyositis: Current hypotheses |
| Q26866133 | The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome |
| Q47346613 | The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activation |
| Q55260402 | Tolerogenic β2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome. |
| Q37871051 | β(2) -Glycoprotein I: evolution, structure and function. |
| Q60961044 | β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease |
| Q35126642 | β2-Glycoprotein I-specific T cells are associated with epitope spread to lupus-related autoantibodies |
Search more.